ENDRA Life Sciences Inc (NDRA)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -567.485 | -162.57 | -146.79 | -243.434 | -152.073 | -104.917 | -119.003 | -125.53 |
Return on Equity (%) | 861.801 | -245.469 | -170.025 | -318.423 | -203.219 | -126.464 | -146.531 | -156.418 |
Return on Invested Capital (%) | 556.211 | -211.185 | -151.54 | -197.002 | -187.543 | -125.572 | -146.148 | -219.121 |
Operating Margin (%) | -537.791 | -1527.557 | -163266.667 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -537.791 | -1527.557 | -163266.667 | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -0.353 | 1.345 | 0.842 | 0.565 | 0.211 | 0.253 | 2.088 | 0.651 |
Earnings Per Share | -1.096 | -1.371 | -1.32 | -2.081 | -0.356 | -0.266 | -3.819 | -1.157 |
Cash Per Share | 0.057 | 1.428 | 0.872 | 0.733 | 0.212 | 0.222 | 1.417 | 0.326 |
Working Capital Per Share | -0.47 | 1.283 | 0.805 | 0.53 | 0.212 | 0.247 | 1.977 | 0.245 |
Operating Profit Per Share | 0.136 | 0.061 | 0.001 | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.096 | -1.371 | -1.32 | -1.58 | -0.344 | -0.263 | -3.819 | -1.157 |
EBITDA Per Share | -1.096 | -1.371 | -1.32 | -1.58 | -0.344 | -0.263 | -3.819 | -1.157 |
Free Cash Flow Per Share | -1.122 | -1.384 | -1.315 | -2.086 | -0.357 | -0.268 | -3.788 | -1.167 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,53M | 3,92M | 7,42M | 8,42M | 34,05M | 42,56M | 3,17M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 3,17M | N/A | 7,48M | 8,41M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,02M |
Ratio cours/bénéfice | -0,27 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 0,97 |
Ratio prix/valeur comptable | 0,48 |
Rendement de dividende | - |
Actions en circulation | 536,91k |
Volume moyen (1 semaine) | 30,77k |
Volume moyen (1 mois) | 28,24k |
Variation sur 52 semaines | -99,72% |
Plus haut sur 52 semaines | 2 240,00 |
Plus bas sur 52 semaines | 4,01 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales